Page last updated: 2024-10-27

gabexate and Granulocytic Leukemia

gabexate has been researched along with Granulocytic Leukemia in 1 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sakata, Y1

Reviews

1 review available for gabexate and Granulocytic Leukemia

ArticleYear
[Treatment of DIC associated with myelogenous leukemia].
    Nihon rinsho. Japanese journal of clinical medicine, 2009, Volume: 67, Issue:10

    Topics: Anticoagulants; Disseminated Intravascular Coagulation; Gabexate; Heparin; Humans; Leukemia, Myeloid

2009